Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
BACKGROUND: There are few data on predictors of HIV progression in untreated children in resource-limited settings. METHODS: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value...
Hlavní autoři: | Walker, A, Mulenga, V, Sinyinza, F, Lishimpi, K, Nunn, A, Chintu, C, Gibb, D |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2006
|
Podobné jednotky
-
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Autor: Chintu, C, a další
Vydáno: (2004) -
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Autor: Walker, A, a další
Vydáno: (2007) -
Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
Autor: Walker, A, a další
Vydáno: (2009) -
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
Autor: Haberer, J, a další
Vydáno: (2011) -
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.
Autor: Jessica E Haberer, a další
Vydáno: (2011-04-01)